CHRISTINA LAO: Open Payments
NPI 1427502681 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,678 in 164 payments from 34 companies in 2025. Trend: 2023 $3,933 · 2024 $5,800 · 2025 $4,678
Food & beverage: $4,040Education: $455Long term medical supply or device loan: $183
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 17 | $506 |
| Astellas Pharma US Inc | 10 | $440 |
| AstraZeneca Pharmaceuticals LP | 8 | $353 |
| Eisai Inc. | 18 | $348 |
| Novartis Pharmaceuticals Corporation | 11 | $340 |
| Merck Sharp & Dohme LLC | 8 | $298 |
| Janssen Biotech, Inc. | 9 | $228 |
| Stemline Therapeutics Inc. | 4 | $207 |
| Tactile Systems Technology Inc | 3 | $200 |
| SEAGEN INC. | 2 | $180 |
Products named: Enhertu, Lenvima, KEYTRUDA, KISQALI, Orserdu, Flexitouch Plus, Vyloy, Trodelvy.
Industry payments across NY — which companies pay providers there.
